NCT05529394

Brief Summary

Effect of storage condition on CD47 expression level in platelet concentrate

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2022

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 2, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 7, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

December 20, 2022

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

September 7, 2022

Status Verified

September 1, 2022

Enrollment Period

2.5 years

First QC Date

September 2, 2022

Last Update Submit

September 2, 2022

Conditions

Platelet Storage Pool Deficiency

Outcome Measures

Primary Outcomes (1)

  • Assessment of CD47 expression level on platelets by exposure to different storage temperatures

    To increase survival time of platelets

    3 years

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Effect of storage condition on CD47 expression level in platelet concentrate

You may qualify if:

  • donors met AABB criteria

You may not qualify if:

  • donors not met AABB criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Platelet Storage Pool Deficiency

Condition Hierarchy (Ancestors)

Blood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesBlood Platelet DisordersHemorrhagic Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident doctor

Study Record Dates

First Submitted

September 2, 2022

First Posted

September 7, 2022

Study Start

December 20, 2022

Primary Completion

July 1, 2025

Study Completion

December 1, 2025

Last Updated

September 7, 2022

Record last verified: 2022-09